| Hans-Günter Meyer-Thompson | Naloxon
Naloxon. Indivior’s NALSCUE® Receives Marketing Authorization from French Regulatory Agency ANSM
French Regulatory Agency ANSM Approves Marketing Authorisation for Indivior’s NALSCUE® (Naloxone Hydrochloride) Nasal Spray for the Emergency Treatment of Characterized or Suspected Opioid Overdose
Ready-to-use, Needle-free Device Can Temporarily Reverse Characterized or Suspected Opioid Overdose Within Minutes. (Indivior, 31.07.2017)